The FDA approved Qalsody (tofersen), a drug intended to treat amyotrophic lateral sclerosis with a rare mutation called the superoxide dismutase 1 gene, on April 25.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves therapy for ALS patients with rare gene mutation
